UNH.F
UnitedHealth Group Incorporated
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
334.80
▲ 5.60 (1.70%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
329.60
Prev close
329.20
Day high
334.80
Day low
329.60
Volume
1.52K
Market cap
$300.51B
P/E (TTM)
25.12
52W range
221.95 – 390.00
Day trading desk
Gap from prior close
+0.12%
Prior close 329.20
VWAP
334.44
+0.11% from price
Relative volume
11.12×
Unusually busy
Session range
1.58%
329.60 – 334.80
Position in range
100%
Near session high
ATR (14D)
5.44
1.63% of price
Prior day high
333.80
PDH
Prior day low
329.20
PDL
Bid / ask spread
—
Quote not published
Session volume
3.02K
Avg 272
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.07%
-1.7%
1M
-10.14%
-13.9%
3M
+0.66%
-2.4%
6M
+35.99%
+24.9%
YTD
+19.57%
+7.3%
1Y
+27.71%
+7.7%
3Y
-26.42%
-100.6%
5Y
-1.95%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on UNH.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
2.23M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 5, 26 | CONWAY PATRICK HUGH Officer |
SELL | 500 | $205.00K | Direct |
| Jul 1, 26 | MCNABB FREDERICK WILLIAM III Director |
STOCK | 250 | $0 | Direct |
| Jul 1, 26 | MONTGOMERY RICE VALERIE C Director |
STOCK | 220 | $0 | Direct |
| Jul 1, 26 | GIL KRISTEN Director |
STOCK | 206 | $0 | Direct |
| Jul 1, 26 | NOSEWORTHY JOHN H Director |
STOCK | 206 | $0 | Direct |
| Jul 1, 26 | GARCIA PAUL REU Director |
STOCK | 220 | $0 | Direct |
| Jul 1, 26 | GOTTLIEB SCOTT Director |
STOCK | 210 | $0 | Direct |
| Jul 1, 26 | FLYNN TIMOTHY PATRICK Director |
STOCK | 225 | $0 | Direct |
| Jul 1, 26 | BAKER CHARLES D Director |
STOCK | 220 | $0 | Direct |
| Jun 23, 26 | MCNABB FREDERICK WILLIAM III Director |
STOCK | 50 | $0 | Direct |
| Jun 23, 26 | MONTGOMERY RICE VALERIE C Director |
STOCK | 41 | $0 | Direct |
| Jun 23, 26 | GIL KRISTEN Director |
STOCK | 8 | $0 | Direct |
| Jun 23, 26 | NOSEWORTHY JOHN H Director |
STOCK | 41 | $0 | Direct |
| Jun 23, 26 | GARCIA PAUL REU Director |
STOCK | 13 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CIANFROCCO HEATHER |
Officer | 22.44K | Stock Award(Grant) |
DEVEYDT WAYNE S |
Chief Financial Officer | 19.78K | Stock Award(Grant) |
FLYNN TIMOTHY PATRICK |
Director | 16.91K | Stock Award(Grant) |
HEMSLEY STEPHEN J |
Chief Executive Officer | 1.06M | Stock Award(Grant) |
HOOPER MICHELE J. |
Director | 41.79K | Stock Award(Grant) |
NOEL TIMOTHY JOHN |
Officer | 17.65K | Stock Award(Grant) |
REX JOHN F |
President | 210.69K | Stock Award(Grant) |
ROOS THOMAS E |
Officer | 31.28K | Stock Award(Grant) |
THOMPSON BRIAN R |
Officer | 32.67K | Stock Award(Grant) |
WITTY ANDREW PHILIP |
Chief Executive Officer | 112.16K | Stock Award(Grant) |
Fundamentals
Market cap$300.51B
Enterprise value$349.88B
Revenue (TTM)$450.53B
Gross profit$88.86B
EBITDA$26.68B
Net income$14.12B
EPS (TTM)$13.33
Free cash flow$24.27B
Total cash$31.47B
Total debt$73.33B
Book value / share$93.97
Shares outstanding897.59M
Float895.02M
Short % of float—
Dividend yield2.40%
Beta (5Y)0.63
Valuation & profitability ratios
Trailing P/E25.12
Forward P/E—
PEG ratio1.21
Price / sales—
Price / book3.56
EV / revenue0.78
EV / EBITDA13.11
Gross margin19.72%
Operating margin7.13%
Profit margin3.14%
Return on equity14.15%
Return on assets4.87%
Debt / equity69.21
Current ratio0.78
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $447.57B | $400.28B | $371.62B | $324.16B | +11.8% |
| Operating revenue | $447.57B | $400.28B | $371.62B | $324.16B | +11.8% |
| Cost of revenue | $364.65B | $310.88B | $280.66B | $244.54B | +17.3% |
| Gross profit | $82.92B | $89.40B | $90.96B | $79.62B | -7.3% |
| Total operating expense | $63.95B | $57.11B | $58.60B | $51.18B | +12.0% |
| Operating income | $18.96B | $32.29B | $32.36B | $28.43B | -41.3% |
| Net interest income | -$4.00B | -$3.91B | -$3.25B | -$2.09B | -2.5% |
| Pre-tax income | $14.70B | $20.07B | $29.11B | $26.34B | -26.8% |
| Tax provision | $1.89B | $4.83B | $5.97B | $5.70B | -60.9% |
| Net income | $12.06B | $14.40B | $22.38B | $20.12B | -16.3% |
| Net income to common | $12.06B | $14.40B | $22.38B | $20.12B | -16.3% |
| Basic EPS | 13.28 | 15.74 | 24.22 | 21.54 | -15.6% |
| Diluted EPS | 13.23 | 15.51 | 23.86 | 21.18 | -14.7% |
| EBIT | $18.70B | $23.98B | $32.36B | $28.43B | -22.0% |
| EBITDA | $23.06B | $28.08B | $36.33B | $31.84B | -17.9% |
| Basic shares | 908.00M | 915.00M | 924.00M | 934.00M | -0.8% |
| Diluted shares | 911.00M | 929.00M | 938.00M | 950.00M | -1.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $24.36B | $25.31B | $25.43B | $23.36B | -3.7% |
| Cash & short-term investments | $28.12B | $29.11B | $29.63B | $27.91B | -3.4% |
| Accounts receivable | $23.02B | $22.36B | $21.28B | $17.68B | +2.9% |
| Total current assets | $90.58B | $85.78B | $78.44B | $69.07B | +5.6% |
| Property, plant & equipment | $10.76B | $10.55B | $11.45B | $10.13B | +2.0% |
| Goodwill & intangibles | $130.97B | $130.00B | $118.93B | $107.75B | +0.7% |
| Total assets | $309.58B | $298.28B | $273.72B | $245.71B | +3.8% |
| Total current liabilities | $114.90B | $103.77B | $99.05B | $89.24B | +10.7% |
| Current debt | $6.07B | $4.54B | $4.27B | $3.11B | +33.5% |
| Long-term debt | $72.32B | $72.36B | $58.26B | $54.51B | -0.1% |
| Total debt | $78.39B | $76.90B | $62.54B | $57.62B | +1.9% |
| Total liabilities | $207.88B | $195.69B | $174.80B | $159.36B | +6.2% |
| Retained earnings | $95.60B | $96.04B | $95.77B | $86.16B | -0.5% |
| Shareholder equity | $94.11B | $92.66B | $88.76B | $77.77B | +1.6% |
| Working capital | -$24.32B | -$17.99B | -$20.62B | -$20.17B | -35.2% |
| Net tangible assets | -$36.86B | -$37.34B | -$30.17B | -$29.98B | +1.3% |
| Shares issued | 905.84M | 915.00M | 924.00M | 934.00M | -1.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $12.81B | $15.24B | $23.14B | $20.64B | -16.0% |
| Depreciation & amortisation | $4.36B | $4.10B | $3.97B | $3.40B | +6.4% |
| Stock-based compensation | $971.00M | $1.02B | $1.06B | $925.00M | -4.6% |
| Change in working capital | $2.28B | -$808.00M | $1.64B | $2.25B | +382.4% |
| Operating cash flow | $19.70B | $24.20B | $29.07B | $26.21B | -18.6% |
| Capital expenditure | -$3.62B | -$3.50B | -$3.39B | -$2.80B | -3.5% |
| Investing cash flow | -$8.69B | -$20.53B | -$15.57B | -$28.48B | +57.7% |
| Share buybacks | -$5.54B | -$9.00B | -$8.00B | -$7.00B | +38.4% |
| Dividends paid | -$7.92B | -$7.53B | -$6.76B | -$5.99B | -5.1% |
| Financing cash flow | -$11.64B | -$3.51B | -$11.53B | $4.23B | -231.5% |
| Free cash flow | $16.07B | $20.70B | $25.68B | $23.40B | -22.4% |
| End cash position | $24.36B | $25.31B | $25.43B | $23.36B | -3.7% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | — | -1.3% |
| Operating revenue | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | — | -1.3% |
| Cost of revenue | $86.31B | $94.72B | $92.52B | $91.60B | $85.80B | — | -8.9% |
| Gross profit | $25.41B | $18.49B | $20.64B | $20.01B | $23.77B | — | +37.4% |
| Total operating expense | $16.42B | $18.11B | $16.32B | $14.86B | $14.65B | — | -9.4% |
| Operating income | $8.99B | $380.00M | $4.32B | $5.15B | $9.12B | — | +2,265.8% |
| Net interest income | -$955.00M | -$974.00M | -$1.00B | -$1.03B | -$998.00M | — | +2.0% |
| Pre-tax income | $7.96B | -$720.00M | $3.23B | $4.08B | $8.11B | — | +1,206.0% |
| Tax provision | $1.48B | -$938.00M | $686.00M | $510.00M | $1.63B | — | +258.0% |
| Net income | $6.28B | $10.00M | $2.35B | $3.41B | $6.29B | — | +62,700.0% |
| Net income to common | $6.28B | $10.00M | $2.35B | $3.41B | $6.29B | — | +62,700.0% |
| Basic EPS | 6.92 | 0.01 | 2.59 | 3.76 | 6.91 | — | +62,575.7% |
| Diluted EPS | 6.90 | 0.01 | — | 3.74 | 6.85 | 5.98 | +68,900.0% |
| EBIT | $8.92B | $254.00M | $4.23B | $5.11B | $9.10B | — | +3,411.0% |
| EBITDA | $9.95B | $1.37B | $5.33B | $6.19B | $10.16B | — | +625.5% |
| Basic shares | 907.68M | 905.84M | 905.67M | 905.00M | 910.00M | — | +0.2% |
| Diluted shares | 910.00M | 910.00M | — | 910.00M | 918.00M | 927.00M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | +14.9% |
| Cash & short-term investments | $31.23B | $28.12B | $30.61B | $32.02B | $34.29B | +11.1% |
| Accounts receivable | $26.59B | $23.02B | $22.67B | $24.14B | $26.94B | +15.5% |
| Total current assets | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | +0.6% |
| Property, plant & equipment | $10.67B | $10.76B | $11.10B | $10.92B | $10.73B | -0.9% |
| Goodwill & intangibles | $130.60B | $130.97B | $133.13B | $130.19B | $130.51B | -0.3% |
| Total assets | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | +1.0% |
| Total current liabilities | $114.12B | $114.90B | $115.53B | $110.78B | $113.47B | -0.7% |
| Current debt | $6.48B | $6.07B | $7.74B | $5.70B | $9.99B | +6.7% |
| Long-term debt | $71.44B | $72.32B | $72.40B | $73.50B | $71.28B | -1.2% |
| Total debt | $77.92B | $78.39B | $80.14B | $79.19B | $81.27B | -0.6% |
| Total liabilities | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | -0.3% |
| Retained earnings | $99.88B | $95.60B | $97.59B | $97.25B | $97.93B | +4.5% |
| Shareholder equity | $97.88B | $94.11B | $95.79B | $94.72B | $95.04B | +4.0% |
| Working capital | -$23.00B | -$24.32B | -$20.46B | -$17.08B | -$17.19B | +5.4% |
| Net tangible assets | -$32.72B | -$36.86B | -$37.34B | -$35.46B | -$35.48B | +11.2% |
| Shares issued | 907.68M | 905.84M | 905.67M | 905.00M | 910.00M | +0.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $6.48B | $218.00M | $2.54B | $3.57B | $6.47B | +2,872.9% |
| Depreciation & amortisation | $1.03B | $1.12B | $1.10B | $1.08B | $1.06B | -7.9% |
| Stock-based compensation | $348.00M | $176.00M | $223.00M | $197.00M | $375.00M | +97.7% |
| Change in working capital | $746.00M | -$495.00M | $2.99B | $2.42B | -$2.63B | +250.7% |
| Operating cash flow | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | +704.3% |
| Capital expenditure | -$763.00M | -$948.00M | -$890.00M | -$886.00M | -$898.00M | +19.5% |
| Investing cash flow | -$2.45B | -$2.61B | -$4.56B | -$1.44B | -$74.00M | +6.3% |
| Share buybacks | $0 | $0 | $0 | -$2.54B | -$3.00B | — |
| Dividends paid | -$2.00B | -$2.00B | -$2.00B | -$2.00B | -$1.91B | -0.1% |
| Financing cash flow | -$2.99B | -$1.03B | -$2.77B | -$7.95B | $99.00M | -190.2% |
| Free cash flow | $8.15B | $160.00M | $5.05B | $6.30B | $4.56B | +4,993.1% |
| End cash position | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | +14.9% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $111.49B | -1.5% |
| Next quarter | — | — | $111.28B | -1.7% |
| Current year | — | — | $446.53B | -0.2% |
| Next year | — | — | $459.36B | +2.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.25%
Held by institutions89.64%
Institutions holding4.37K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
343.12
-2.42% from price
SMA 20
352.45
-5.01% from price
SMA 50
362.04
-7.52% from price
SMA 100
336.93
-0.63% from price
SMA 200
300.61
+11.38% from price
EMA 12
343.65
-2.58% from price
EMA 26
351.98
-4.88% from price
EMA 50
351.85
-4.85% from price
RSI (14)
36.6
Neutral
MACD (12,26,9)
-8.33
Hist -2.49
ATR (14)
5.44
1.63% of price
Realised vol 30D
29.9%
Annualised
Bollinger upper
377.60
20, 2σ
Bollinger lower
327.30
20, 2σ
50 / 200 cross
Golden
362.04 vs 300.61
Trend bias
Above 200
+11.38%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.38
Less volatile than market
Correlation to SPY
0.13
Largely independent
Realised vol 30D
29.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-29.7%
Peak to trough
Max drawdown 5Y
-64.9%
Peak to trough
ATR 14
5.44
1.63% of price
Beta (reported)
0.63
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 21, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 21, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 20, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 17, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 17, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Jul 17, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Jul 17, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 17, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 17, 26 | UBS | MAINTAINED | Buy | Buy |
| Jul 16, 26 | Baird | UPGRADE | Underperform | Neutral |
| Jul 14, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Jul 14, 26 | Truist Securities | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate$8.04 / yr
Forward yield2.40%
5-year avg yield1.66%
Payout ratio57.52%
Ex-dividend dateSep 14, 2026
Next pay date—
Last split—
Split date—
Headlines
Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?
Insider Monkey · 7m ago
Dow Jones Futures: Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 10m ago
An $808 monthly payment is reshaping who can afford a new car
TheStreet · 16m ago
UPS Stopped Carrying 2 Million Amazon Packages a Day. Amazon Still Has to Move Them.
Motley Fool · 19m ago
Treasury Market Still Functioning, Fed's Kashkari Says
Bloomberg · 20m ago
Former cricket captains appeal to Pakistan over Khan health care
AFP · 21m ago
3 Growth Stocks That Could Skyrocket in the Second Half of 2026
Motley Fool · 21m ago
Nvidia Notifies Customers About AI-Related Price Hikes
Bloomberg · 23m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.